Şükrü AYDIN, Mehmet Turan ÇİÇEK

An unexpected complication after parotidectomy; severe bleeding due to systemic thrombolytic therapy for the treatment of pulmonary thromboembolism

Pulmonary thromboembolism (PTE) is a serious cause of morbidity and mortality after surgery. Since most deaths occur within the first hour of patients, rapid thrombolytic treatment is lifesaving. In this article, a patient who was administered systemic thrombolytic therapy due to PTE after head and neck surgery was discussed. No additional prophylaxis was applied to the patient except for early ambulation. Since PTE has caused hemodynamic instability in the patient, systemic thrombolytics was administered, the PTE was successfully treated but a second surgical intervention was performed to control the bleeding from the surgical site. Systemic thrombolysis for treatment of PTE in otolaryngology surgery patients may be necessary but the morbidity of the bleeding in the surgical site should be considered.

PDF

___

1. Moreano EH, Hutchison JL, McCulloch TM, et al. Incidence of deep venous thrombosis and pulmonary embolism in otolaryngology-head and neck surgery. Otolaryngol Head Neck Surg. 1998;118:777–84.

2. Zhang K, Zeng X, Zhu C, et al. Successful thrombolysis in postoperative patients with acute massive pulmonary embolism. Heart Lung Circ. 2013;22:100-3.

3. Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidencebased clinical practice guidelines-8th edition. Chest. 2008;133:454–545.

4. Ah-See KW, Kerr J, Sim DW. Prophylaxis for venous thromboembolism in head and neck surgery: the practice of otolaryngologists. J Laryngol Otol. 1997;111:845–9.

5. Ota M, Nakamura M, Yamada N, et al. Prognostic significance of early diagnosis in acute pulmonary thromboembolism with circulatory failure. Heart Vessels. 2002;17:7–11.

6. Van Belle A, Buller HR, Huisman MV, et al. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, d-dimer testing, and computed tomography. JAMA. 2006;295:172–9.

7. Sakuma M, Konno Y, Shirato K. Increasing mortality from pulmonary embolism in Japan 1951–2000. Circ J. 2002;66:1144–9.

8. Buller HR, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126:401–28.

9. Wan S, Quinlan DJ, Agnelli G, et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation. 2004;110:744–9.

10. Daley MJ, Lat I. Clinical controversies in thrombolytic therapy for the management of acute pulmonary embolism. Pharmacotherapy. 2012;32:158–72.